Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-1 receptor antagonism

D J Nikolic-Paterson1, H Y Lan, R C Atkins

  • 1Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia.

Seminars in Nephrology
|November 1, 1996
PubMed
Summary

Interleukin-1 (IL-1) drives inflammation, but IL-1 receptor antagonist (IL-1ra) blocks its effects. IL-1ra therapy suppressed experimental glomerulonephritis, suggesting its potential for treating human kidney disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Study on the characteristics and differences of intestinal microbiota in children with allergic diseases].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2026
Same author

Transmutation of long-lived fission products in an advanced nuclear energy system.

Scientific reports·2022
Same author

Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies.

Diabetic medicine : a journal of the British Diabetic Association·2017
Same author

Establishment of a novel triple-transgenic mouse: conditionally and liver-specifically expressing hepatitis C virus NS3/4A protease.

Molecular biology reports·2014
Same author

Expression profile of macrophage migration-inhibitory factor in human gingiva and reconstituted human gingival epithelia stimulated by Porphyromonas gingivalis lipopolysaccharide.

Journal of periodontal research·2013
Same author

miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes.

Diabetologia·2013

Area of Science:

  • Immunology
  • Nephrology
  • Cytokine Biology

Background:

  • Interleukin-1 (IL-1) is a key pro-inflammatory cytokine.
  • IL-1 mediates diverse biological effects crucial in immune responses.
  • Understanding IL-1's role is vital for inflammatory disease research.

Purpose of the Study:

  • To investigate the role of IL-1 in glomerulonephritis.
  • To evaluate the therapeutic potential of IL-1 receptor antagonist (IL-1ra) in experimental crescentic glomerulonephritis.

Main Methods:

  • Utilized IL-1 receptor antagonist (IL-1ra) to block IL-1 activity in vivo.
  • Studied the induction and progression of experimental crescentic glomerulonephritis.

Main Results:

  • IL-1ra treatment demonstrated the ability to suppress the induction of experimental crescentic glomerulonephritis.
  • IL-1ra treatment also suppressed the progression of experimental crescentic glomerulonephritis.

Conclusions:

  • IL-1 production is important in the pathogenesis of glomerulonephritis.
  • IL-1ra represents a promising adjunctive therapy for progressive glomerulonephritis.
  • Further clinical studies are warranted to confirm IL-1ra efficacy in human patients.

Related Experiment Videos